Influenza surveillance in England and Wales: October 1997 to June 1998. 1998

D J Dedman, and M Zambon, and P V Buynder, and D M Fleming, and J M Watson, and C A Joseph
Epidemiology Division/PHLS Communicable Disease Surveillance Centre, London.

Influenza caused low levels of mortality and morbidity in England and Wales in the 1997/98 season. Influenza viruses of the H3N2 and H1N1 subtypes were isolated in small numbers from community and hospital patients in November and December. Their numbers subsequently increased to peak in February, H1N1 a week or two before H3N2. Most of the H1N1 isolates were similar to the A/Bayern/7/95-like virus, included in the vaccine recommended for 1997-98, whereas most H3N2 isolates were A/Sydney/5/97-like, a virus not covered by the season's vaccine but recommended for 1998/99. Consultation rates in general practice for influenza-like illnesses remained low until early February, when a small increase coincided with the increase in laboratory confirmed influenza. Fewer deaths directly attributed to influenza were registered during the surveillance period than in recent years. Localised outbreaks occurred in schools and nursing homes towards the end of the winter.

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D009981 Influenza B virus Species of the genus BETAINFLUENZAVIRUS that cause HUMAN INFLUENZA and other diseases primarily in humans. Antigenic variation is less extensive than in type A viruses (INFLUENZA A VIRUS) and consequently there is no basis for distinct subtypes or variants. Epidemics are less likely than with INFLUENZA A VIRUS and there have been no pandemics. Previously only found in humans, Influenza B virus has been isolated from seals which may constitute the animal reservoir from which humans are exposed. Betainfluenzavirus influenzae,FLUBV,Human Influenza B Virus,Influenza Viruses Type B,Influenza virus type B,Orthomyxoviruses Type B,Influenza B viruses
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D004739 England A part of Great Britain within the United Kingdom.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014852 Wales A region of the United Kingdom, in the southwestern area of Great Britain.

Related Publications

D J Dedman, and M Zambon, and P V Buynder, and D M Fleming, and J M Watson, and C A Joseph
December 1999, Communicable disease and public health,
D J Dedman, and M Zambon, and P V Buynder, and D M Fleming, and J M Watson, and C A Joseph
December 1994, Communicable disease report. CDR review,
D J Dedman, and M Zambon, and P V Buynder, and D M Fleming, and J M Watson, and C A Joseph
December 1993, Communicable disease report. CDR review,
D J Dedman, and M Zambon, and P V Buynder, and D M Fleming, and J M Watson, and C A Joseph
December 1995, Communicable disease report. CDR review,
D J Dedman, and M Zambon, and P V Buynder, and D M Fleming, and J M Watson, and C A Joseph
November 1996, Communicable disease report. CDR review,
D J Dedman, and M Zambon, and P V Buynder, and D M Fleming, and J M Watson, and C A Joseph
December 2000, Communicable disease and public health,
D J Dedman, and M Zambon, and P V Buynder, and D M Fleming, and J M Watson, and C A Joseph
December 1992, Communicable disease report. CDR review,
D J Dedman, and M Zambon, and P V Buynder, and D M Fleming, and J M Watson, and C A Joseph
October 1991, CDR (London, England : Review),
D J Dedman, and M Zambon, and P V Buynder, and D M Fleming, and J M Watson, and C A Joseph
October 1998, Communicable disease report. CDR weekly,
D J Dedman, and M Zambon, and P V Buynder, and D M Fleming, and J M Watson, and C A Joseph
October 1998, Communicable disease report. CDR weekly,
Copied contents to your clipboard!